image
Galmed Pharmaceuticals Ltd. GLMD
Healthcare - Biotechnology - NASDAQ - IL
Watchlist
$ 2.93
-5.48 %
$ 4.42 M
Market Cap
-0.27
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
7.49 M OPERATING INCOME
142.45%
Growth Rates
1Year 142.45%
3Years 31.00%
5Years 21.97%
7Years 13.62%
10Years 9.66%
-6.91 M NET INCOME
61.31%
Growth Rates
1Year 61.31%
3Years 37.83%
5Years 6.85%
7Years 12.03%
10Years 8.86%
EFFICIENCY
Earnings Waterfall Galmed Pharmaceuticals Ltd.
image
Revenue 0
Cost Of Revenue 31 K
Gross Profit -31 K
Operating Expenses -7.49 M
Operating Income 7.49 M
Other Expenses 14.4 M
Net Income -6.91 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 0 0 2.0 1.1 0.5 0 0 0 0
GROSS PROFIT
Cost Of Revenue 31 K 35 K 42 K 39 K 35 K 0 0 0 50 K 0 0 0
Gross Profit 31 K 35 K 42 K 39 K 35 K 2.0 1.1 0.5 50 K 0 0 0
OPERATING INCOME
Operating Expenses (7.5) 17.7 32.9 30.2 22.4 12.8 13.4 17.3 10.9 9.1 14.6 3.1
Selling, General and Administrative Expenses 3.9 4.7 5.7 4.1 4.2 4.4 3.8 3.1 3.2 2.5 7.4 0.7
Research and Development Expenses 3.6 13.0 27.2 26.1 18.2 8.3 9.7 14.3 7.6 6.7 7.2 2.4
Operating Income 7.5 (17.7) (32.9) (30.2) (22.4) (10.7) (12.4) (16.9) (10.9) (9.1) (14.6) (3.1)
PRE-TAX INCOME
Interest Income Expense 11 K 0.2 43 K 31 K 33 K 42 K 49 K 67 K 0 0 0 0
Total Other Income (14.4) (0.2) 0.4 1.4 1.9 0.9 65 K 35 K 0.3 40 K (2.9) 6 K
Pre-Tax Income (6.9) (17.9) (32.5) (28.8) (20.5) (9.8) (12.3) (16.8) (10.6) (9.1) (17.5) (3.1)
NET INCOME
Tax Provision 0 0.7 (0.5) (1.2) (1.9) 75 K 12.4 0.1 21.2 1 K 1 K 6 K
Net Income (6.9) (18.6) (31.9) (27.6) (18.5) (9.9) (12.3) (17.0) (10.6) (9.1) (17.5) (3.1)
EPS 30.1 11.1 19.5 19.5 13.2 8.15 14.8 22.4 14.3 13.2 24.6 9.32